<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rentrad</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник рентгенологии и радиологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of radiology and nuclear medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0042-4676</issn><issn pub-type="epub">2619-0478</issn><publisher><publisher-name>Limited Liability Company "LUCHEVAYA DIAGNOSTIKA", Russian Association of Radiologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20862/0042-4676-2019-100-2-116-124</article-id><article-id custom-type="elpub" pub-id-type="custom">rentrad-451</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Роль МРТ диффузионно-взвешенного исследования и МР-исследования с динамическим контрастным усилением в корреляции с системой Adnexa MR scoring system в диагностике опухолей яичников</article-title><trans-title-group xml:lang="en"><trans-title>The Role of Diffusion-weighted MRI and Follow-up Contrast-enhanced MRI in Correlation with the Adnexa MR Scoring System in the Diagnosis of Uterine Appendage Tumors</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3532-8201</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Олимов</surname><given-names>Б. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Olimov</surname><given-names>B. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Олимов Бехруз Парвизович, аспирант</p><p>ул. Баррикадная, 2/1, стр. 1, Москва, 125993</p></bio><bio xml:lang="en"><p>Bekhruz P. Olimov, Postgraduate</p><p>ul. Barrikadnaya, 2/1, stroenie 1, Moscow, 125993</p></bio><email xlink:type="simple">AlimovBP90@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3459-8832</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коссов</surname><given-names>Ф. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kossov</surname><given-names>F. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Коссов Филипп Андреевич, аспирант</p><p>ул. Баррикадная, 2/1, стр. 1, Москва, 125993</p></bio><bio xml:lang="en"><p>Filipp A. Kossov, Postgraduate</p><p>ul. Barrikadnaya, 2/1, stroenie 1, Moscow, 125993</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9097-0267</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стрельцова</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Strel’tsova</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Стрельцова Ольга Николаевна, кандидат медицинских наук, врач-рентгенолог, НИИ клинической и экспериментальной радиологии </p><p>Каширское ш., 23, Москва, 115478</p></bio><bio xml:lang="en"><p>Ol’ga N. Strel’tsova, Cand. Med. Sc., Radiologist, Research Institute of Clinical and Experimental Radiology</p><p>Kashirskoe shosse, 23, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7534-4818</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Панов</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Panov</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Панов Вадим Олегович, кандидат медицинских наук, доцент кафедры радиологии и рентгенологии, ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России; ведущий научный сотрудник, НИИ клинической и экспериментальной радиологии ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России</p><p>ул. Баррикадная, 2/1, стр. 1, Москва, 125993, Каширское ш., 23, Москва, 115478</p></bio><bio xml:lang="en"><p>Vadim O. Panov, Cand. Med. Sc., Associate Professor of Chair of Radiology, Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation; Leading Researcher, Research Institute of Clinical and Experimental Radiology, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation</p><p>ul. Barrikadnaya, 2/1, stroenie 1, Moscow, 125993, Kashirskoe shosse, 23, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8467-6942</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Паниченко</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Panichenko</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Паниченко Игорь Валерьянович, доктор медицинских наук, НИИ клинической онкологии им. Н.Н. Трапезникова</p><p>Каширское ш., 23, Москва, 115478</p></bio><bio xml:lang="en"><p>Igor’ V. Panichenko, Dr. Med. Sc.</p><p>Kashirskoe shosse, 23, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0480-8467</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буйденок</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Buydenok</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Буйденок Юрий Владимирович, доктор медицинских наук, профессор, ведущий научный сотрудник, НИИ клинической и экспериментальной радиологии</p><p>Каширское ш., 23, Москва, 115478</p></bio><bio xml:lang="en"><p>Yuriy V. Buydenok, Dr. Med. Sc., Professor, Leading Researcher, Research Institute of Clinical and Experimental Radiology</p><p>Kashirskoe shosse, 23, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3931-1431</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тюрин</surname><given-names>И. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Tyurin</surname><given-names>I. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тюрин Игорь Евгеньевич, доктор медицинских наук, профессор, заведующий кафедрой радиологии и рентгенологии, ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России; ведущий научный сотрудник, НИИ клинической и экспериментальной радиологии ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России</p><p>ул. Баррикадная, 2/1, стр. 1, Москва, 125993, Каширское ш., 23, Москва, 115478</p></bio><bio xml:lang="en"><p>Igor’ E. Tyurin, Dr. Med. Sc., Professor, Chief of Radiology Chair, Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation; Leading Researcher, Research Institute of Clinical and Experimental Radiology, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation</p><p>ul. Barrikadnaya, 2/1, stroenie 1, Moscow, 125993, Kashirskoe shosse, 23, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России;&#13;
ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation;&#13;
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>22</day><month>05</month><year>2019</year></pub-date><volume>100</volume><issue>2</issue><fpage>116</fpage><lpage>124</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Олимов Б.П., Коссов Ф.А., Стрельцова О.Н., Панов В.О., Паниченко И.В., Буйденок Ю.В., Тюрин И.Е., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Олимов Б.П., Коссов Ф.А., Стрельцова О.Н., Панов В.О., Паниченко И.В., Буйденок Ю.В., Тюрин И.Е.</copyright-holder><copyright-holder xml:lang="en">Olimov B.P., Kossov F.A., Strel’tsova O.N., Panov V.O., Panichenko I.V., Buydenok Y.V., Tyurin I.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.russianradiology.ru/jour/article/view/451">https://www.russianradiology.ru/jour/article/view/451</self-uri><abstract><p>Проанализированы данные зарубежных и отечественных исследований, опубликованных за последние 10 лет, посвященных основным методам и подходам лучевой диагностики объемных образований яичников, как на основе ультразвукового исследования с цветовым доплеровским картированием, так и использования комплексных подходов магнитно-резонансной томографии (МРТ) в комбинации рутинной МРТ, диффузионно-взвешенных исследований и динамической МРТ с контрастным усилением. Показано, что только комплексное внедрение вышеуказанных методов лучевой диагностики позволяет достичь необходимой чувствительности и специфичности диагностики опухолей яичников. Рассмотрена система оценки с использованием индекса риска злокачественности опухолей яичников с учетом менопаузального статуса, онкомаркера СА-125 и данных УЗИ. Представлена Adnexa MR scoring system, основанная на системе BI-RADS (Breast Imaging Reporting and Data System), со схемами подсчета и анализа риска злокачественности опухолей яичников с учетом определенных МР-критериев.</p></abstract><trans-abstract xml:lang="en"><p>The paper analyzes the data available in the foreign and Russian literature over the past 10 years on main radiodiagnostic techniques and approaches in case of ovarian space-occupying lesions, by using both ultrasonic color Doppler mapping and complex MRI approaches in combination with routine MRI, diffusion-weighted MRI studies, and follow-up contrast-enhanced MRI. It shows that only the comprehensive introduction of the above radiodiagnostic techniques can achieve the necessary sensitivity and specificity of diagnosis of ovarian tumors. The system for assessing the risk index for ovarian tumor malignancy is discussed, by taking into account the menopausal status, the tumor marker CA-125, and ultrasonographic findings. The paper presents the Adnexa MR scoring system based on the breast imaging-reporting and data system (BI-RADS) that gives schemes for calculating and analyzing the risk of ovarian tumor malignancy in terms of certain MR criteria.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>объемные образования яичников</kwd><kwd>магнитно-резонансная томография</kwd><kwd>диффузионно-взвешенные изображения</kwd><kwd>динамическая магнитно-резонансная томография с контрастным усилением</kwd><kwd>индекс риска злокачественности</kwd><kwd>Adnexa MR scoring system</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ovarian tumors</kwd><kwd>magnetic resonance imaging</kwd><kwd>diffusion weighted images</kwd><kwd>dynamic contrast enhancement</kwd><kwd>index risk of malignant</kwd><kwd>Adnexa MR scoring system</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Wanqing Chen, Rongshou Zheng, Peter P.D., Zhang S., Zeng H., Bray F. et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 2016; 66: 115–32. DOI: 10.3322/caac.21338</mixed-citation><mixed-citation xml:lang="en">Wanqing Chen, Rongshou Zheng, Peter P.D., Zhang S., Zeng H., Bray F. et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 2016; 66: 115–32. DOI: 10.3322/caac.21338</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fang Wang, Yanfen Ye, Xia Xu, Xuehui Zhou, Jinhua Wang, Xiaoxiang Chen. CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery. J. Ovarian. Res. 2013; 6; 14. DOI: 10.1186/1757-2215-6-14</mixed-citation><mixed-citation xml:lang="en">Fang Wang, Yanfen Ye, Xia Xu, Xuehui Zhou, Jinhua Wang, Xiaoxiang Chen. CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery. J. Ovarian. Res. 2013; 6; 14. DOI: 10.1186/1757-2215-6-14</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bast R.C., Badgwell D., Lu Z., Marquez R., Rosen D., Liu J.S. et al. New tumor markers: CA 125 and beyond. Int. J. Gynecol. Cancer. 2005; 15 (Suppl. 3): 274–81. DOI: 10.1111/j.1525-1438.2005.00441</mixed-citation><mixed-citation xml:lang="en">Bast R.C., Badgwell D., Lu Z., Marquez R., Rosen D., Liu J.S. et al. New tumor markers: CA 125 and beyond. Int. J. Gynecol. Cancer. 2005; 15 (Suppl. 3): 274–81. DOI: 10.1111/j.1525-1438.2005.00441</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Coccia M.E., Rizzello F., Romanelli Ch., Capezzuoli T. Adnexal masses: what is the role of ultrasonographic imaging? Arch. Gynecol. Obstet. 2014; 290: 843–54. DOI: 10.1007/s00404-014-3327-0</mixed-citation><mixed-citation xml:lang="en">Coccia M.E., Rizzello F., Romanelli Ch., Capezzuoli T. Adnexal masses: what is the role of ultrasonographic imaging? Arch. Gynecol. Obstet. 2014; 290: 843–54. DOI: 10.1007/s00404-014-3327-0</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Foti P.V., Attina G., Spadola S., Caltabiano R., Forina R., Palmucci S., Ettore G.C. MR imaging of ovarian masses: classification and differential diagnosis. Insights Imaging. 2016; 7 (1): 21–41. DOI: 10.1007/s13244-015-0455-4</mixed-citation><mixed-citation xml:lang="en">Foti P.V., Attina G., Spadola S., Caltabiano R., Forina R., Palmucci S., Ettore G.C. MR imaging of ovarian masses: classification and differential diagnosis. Insights Imaging. 2016; 7 (1): 21–41. DOI: 10.1007/s13244-015-0455-4</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mohaghegh P., Rockall A.G. Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques. RadioGraphics. 2012; 32 (6): 1751–73. DOI: 10.1148/rg.326125520</mixed-citation><mixed-citation xml:lang="en">Mohaghegh P., Rockall A.G. Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques. RadioGraphics. 2012; 32 (6): 1751–73. DOI: 10.1148/rg.326125520</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Palmeiro M.M., Cunha T.M. MRI Classification of the Sonographically Indeterminated Adnexal Lesion. Acta Radiol. Portug. Maio-Agosto. 2016; XXVIII (108): 37–47.</mixed-citation><mixed-citation xml:lang="en">Palmeiro M.M., Cunha T.M. MRI Classification of the Sonographically Indeterminated Adnexal Lesion. Acta Radiol. Portug. Maio-Agosto. 2016; XXVIII (108): 37–47.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sohaib S.A., Mills T.D., Sahdev A., Webb J.A., Jacobs I.J., Reznek R.H. The role of magnetic resonance imaging and ultrasound in patients with adnexal masses. Royal Coll. Radiol. Clin. Radiol. 2005; 60: 340–8. DOI: 10.1016/j/crad2004.09.007</mixed-citation><mixed-citation xml:lang="en">Sohaib S.A., Mills T.D., Sahdev A., Webb J.A., Jacobs I.J., Reznek R.H. The role of magnetic resonance imaging and ultrasound in patients with adnexal masses. Royal Coll. Radiol. Clin. Radiol. 2005; 60: 340–8. DOI: 10.1016/j/crad2004.09.007</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Foti P.V., Milone P., Caltabiano R. MR imaging of ovarian masses: classification and differential diagnosis. Insights Imaging. 2016; 7 (1): 21–41. DOI: 10.1007/s13244-015-0455-4</mixed-citation><mixed-citation xml:lang="en">Foti P.V., Milone P., Caltabiano R. MR imaging of ovarian masses: classification and differential diagnosis. Insights Imaging. 2016; 7 (1): 21–41. DOI: 10.1007/s13244-015-0455-4</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Thomassin-Naggara I., Toussaint I., Perrot N., Rouzier R., Bazot M., Darai E. Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiology. 2011; 258 (3): 793–803. DOI: 10.1148/radiol.10100751</mixed-citation><mixed-citation xml:lang="en">Thomassin-Naggara I., Toussaint I., Perrot N., Rouzier R., Bazot M., Darai E. Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiology. 2011; 258 (3): 793–803. DOI: 10.1148/radiol.10100751</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Thomassin-Naggara I., Daraї E., Cuenod Ch.A., Fournier L.S. Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur. Soc. Radiol. 2009. DOI: 10.1007/s00330-009-1299-4</mixed-citation><mixed-citation xml:lang="en">Thomassin-Naggara I., Daraї E., Cuenod Ch.A., Fournier L.S. Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur. Soc. Radiol. 2009. DOI: 10.1007/s00330-009-1299-4</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Forstner R., Thamassin-Naggara I., Cunha T.N., Kinkel K., Masselli G., Spencer J.A., Rockall A. ESUR recommendations for MR omaging of the sonographically indeterminate adnexal mass: an update. Eur. Radiol. 2017; 27 (Issue 6): 2248–57. DOI: 10.1007/soo330-016-4600-3</mixed-citation><mixed-citation xml:lang="en">Forstner R., Thamassin-Naggara I., Cunha T.N., Kinkel K., Masselli G., Spencer J.A., Rockall A. ESUR recommendations for MR omaging of the sonographically indeterminate adnexal mass: an update. Eur. Radiol. 2017; 27 (Issue 6): 2248–57. DOI: 10.1007/soo330-016-4600-3</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mansour S., Wessam R., Raafat M. Diffusion-weighted magnetic resonance imaging in the assessment of ovarian masses with suspicious features: strengths and challenges Radiology Department (Women’s Imaging Unit). Cairo: Kasr El Ainy Hospital, Cairo University, Egypt; 2015.</mixed-citation><mixed-citation xml:lang="en">Mansour S., Wessam R., Raafat M. Diffusion-weighted magnetic resonance imaging in the assessment of ovarian masses with suspicious features: strengths and challenges Radiology Department (Women’s Imaging Unit). Cairo: Kasr El Ainy Hospital, Cairo University, Egypt; 2015.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Vargas H.A., Barrett T., Sala E. MRI of ovarian masses. J. Magn. Reson. Imaging. 2013; 37 (2): 265–81. DOI: 10.1002/jmri.23721</mixed-citation><mixed-citation xml:lang="en">Vargas H.A., Barrett T., Sala E. MRI of ovarian masses. J. Magn. Reson. Imaging. 2013; 37 (2): 265–81. DOI: 10.1002/jmri.23721</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Fan X., Zhang H., Meng S., Zhang J., Zhang C. Role of diffusion-weighted magnetic resonance imaging in differentiating malignancies from benign ovarian tumors. Int. J. Clin. Exp. Med. 2015; 8 (11): 19928–37. PMID 26884905</mixed-citation><mixed-citation xml:lang="en">Fan X., Zhang H., Meng S., Zhang J., Zhang C. Role of diffusion-weighted magnetic resonance imaging in differentiating malignancies from benign ovarian tumors. Int. J. Clin. Exp. Med. 2015; 8 (11): 19928–37. PMID 26884905</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bekiesinska-Figatowska M., Bragoszewska H., Uliasz M., Ceran A., Olzewski A. Magnetic resonance imaging as a diagnostic tool in case of ovarian masses in girls and young women. Med. Sci. Monit. 2007; 13 (1): 116–20. DOI: 10.12659/PJR.900071</mixed-citation><mixed-citation xml:lang="en">Bekiesinska-Figatowska M., Bragoszewska H., Uliasz M., Ceran A., Olzewski A. Magnetic resonance imaging as a diagnostic tool in case of ovarian masses in girls and young women. Med. Sci. Monit. 2007; 13 (1): 116–20. DOI: 10.12659/PJR.900071</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Fujii S., Kakite S., Nishihara K., Nishihara K., Kanasaki Y., Harada T., Ogawa T. Diagnostic accuracy of diffusionweighted imaging in differentiating benign from malignant ovarian lesions. J. Magn. Reson. Imaging. 2008; 28 (5): 1149–56. DOI: 10.1002/jmri.21575</mixed-citation><mixed-citation xml:lang="en">Fujii S., Kakite S., Nishihara K., Nishihara K., Kanasaki Y., Harada T., Ogawa T. Diagnostic accuracy of diffusionweighted imaging in differentiating benign from malignant ovarian lesions. J. Magn. Reson. Imaging. 2008; 28 (5): 1149–56. DOI: 10.1002/jmri.21575</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H., Zhang G.F., He Z.Y., Li Z.Y., Zhu M., Zhang G.X. Evaluation of primary adnexal masses by 3T MRI: categorization with conventional MR imaging and diffusionweighted imaging. J. Ovarian. Res. 2012; 5 (1): 33. DOI: 10.1186/1757-2215-5-33</mixed-citation><mixed-citation xml:lang="en">Zhang H., Zhang G.F., He Z.Y., Li Z.Y., Zhu M., Zhang G.X. Evaluation of primary adnexal masses by 3T MRI: categorization with conventional MR imaging and diffusionweighted imaging. J. Ovarian. Res. 2012; 5 (1): 33. DOI: 10.1186/1757-2215-5-33</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hyun-Jung Kim, So-Yeon Lee, Shin Y.R., Park S.C., Kim K. The value of diffusion-weighted imaging in the differential diagnosis of ovarian lesions: a meta-analysis. PLoS ONE. 2016; 11 (2): e0149465. DOI: 10.1371/journal.pone.0149465</mixed-citation><mixed-citation xml:lang="en">Hyun-Jung Kim, So-Yeon Lee, Shin Y.R., Park S.C., Kim K. The value of diffusion-weighted imaging in the differential diagnosis of ovarian lesions: a meta-analysis. PLoS ONE. 2016; 11 (2): e0149465. DOI: 10.1371/journal.pone.0149465</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yamashita Y., Tang Y., Takahashi M. Ultrafast MR imaging of the abdomen: echo planar imaging and diffusion-weighted imaging. J. Magn. Reson. Imag. DOI: 10.1002/jmri.1880080216</mixed-citation><mixed-citation xml:lang="en">Yamashita Y., Tang Y., Takahashi M. Ultrafast MR imaging of the abdomen: echo planar imaging and diffusion-weighted imaging. J. Magn. Reson. Imag. DOI: 10.1002/jmri.1880080216</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Takao Moteki, Hiroyuki Horikoshi, Keigo Endo. Relationship between apparent diffusion coefficient and signal intensity in endometrial and other pelvic cysts. Magn. Reson. Imaging. 2002; 20 (6): 463–70. PMID 12361793</mixed-citation><mixed-citation xml:lang="en">Takao Moteki, Hiroyuki Horikoshi, Keigo Endo. Relationship between apparent diffusion coefficient and signal intensity in endometrial and other pelvic cysts. Magn. Reson. Imaging. 2002; 20 (6): 463–70. PMID 12361793</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Forstner R., Meissnitzer M.W., Schlattau A., Spencer J.A. MRI in ovarian cancer. Imaging Med. 2012; 4 (1): 59–75.</mixed-citation><mixed-citation xml:lang="en">Forstner R., Meissnitzer M.W., Schlattau A., Spencer J.A. MRI in ovarian cancer. Imaging Med. 2012; 4 (1): 59–75.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Thomassin-Naggara I., Bazot M., Daraї E., Callard P., Cuenod C.A. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. RSNA. 2008. DOI: 10.1148/radiol.2481071120</mixed-citation><mixed-citation xml:lang="en">Thomassin-Naggara I., Bazot M., Daraї E., Callard P., Cuenod C.A. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. RSNA. 2008. DOI: 10.1148/radiol.2481071120</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Thomassin-Naggara I., Daraї E., Cuenod C.A., Rouzier R., Callard P., Bazot M. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J. Magn. Reson. Imaging. 2008; 28 (1): 111–20. DOI: 10.1002/jmri.21377</mixed-citation><mixed-citation xml:lang="en">Thomassin-Naggara I., Daraї E., Cuenod C.A., Rouzier R., Callard P., Bazot M. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J. Magn. Reson. Imaging. 2008; 28 (1): 111–20. DOI: 10.1002/jmri.21377</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Thomassin-Naggara I., Balvay D., Rockall A., Carette M.F. Added value of assessing adnexal masses with advanced MRI techniques. BioMed Research International. 2015; 2015. Article ID 785206. DOI: 10.1155/2015/785206</mixed-citation><mixed-citation xml:lang="en">Thomassin-Naggara I., Balvay D., Rockall A., Carette M.F. Added value of assessing adnexal masses with advanced MRI techniques. BioMed Research International. 2015; 2015. Article ID 785206. DOI: 10.1155/2015/785206</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Hai-Ming Li, Jin-Wei Qiang, Ma F.H., Zhao S.H. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors. J. Ovarian Research. 2017; 10: 4. DOI: 10.1186/s13048-017-0302-y</mixed-citation><mixed-citation xml:lang="en">Hai-Ming Li, Jin-Wei Qiang, Ma F.H., Zhao S.H. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors. J. Ovarian Research. 2017; 10: 4. DOI: 10.1186/s13048-017-0302-y</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">O’Connor J.P., Jackson A., Parker G.J.M., Jayson G.C. DCEMRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br. J. Cancer. 2007; 96 (2): 189–95. DOI: 10.1038/s/bjc.6603515</mixed-citation><mixed-citation xml:lang="en">O’Connor J.P., Jackson A., Parker G.J.M., Jayson G.C. DCEMRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br. J. Cancer. 2007; 96 (2): 189–95. DOI: 10.1038/s/bjc.6603515</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Goff B.A., Agrew K., Gray H.J., Liao J.B., Urban R.R. A symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass. Gynecol. Oncol. 2017; 147 (2): 291–5. DOI: 10.1016/j.ygyno.2017.08.020</mixed-citation><mixed-citation xml:lang="en">Goff B.A., Agrew K., Gray H.J., Liao J.B., Urban R.R. A symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass. Gynecol. Oncol. 2017; 147 (2): 291–5. DOI: 10.1016/j.ygyno.2017.08.020</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Pereira P.N., Sarian L.O., Yoshida A., Barros R.H.O., Derchain S. Accuracy of the ADNEX MR scoring system based on a simplified MRI protocol for the assessment of adnexal masses. Diagn. Interv. Radiol. 2018; 24 (2): 63–71. DOI: 10.5152/dir.2018.17378</mixed-citation><mixed-citation xml:lang="en">Pereira P.N., Sarian L.O., Yoshida A., Barros R.H.O., Derchain S. Accuracy of the ADNEX MR scoring system based on a simplified MRI protocol for the assessment of adnexal masses. Diagn. Interv. Radiol. 2018; 24 (2): 63–71. DOI: 10.5152/dir.2018.17378</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Рубцова Н.А., Новикова Е.Г., Сыченкова И.Ю. Современные возможности магнитно-резонансной томографии в диагностике рака яичников. Исследования и практика в медицине. 2017; 4 (1): 40–8. DOI: 10.17709/2409-2231-2017-4-1-5</mixed-citation><mixed-citation xml:lang="en">Rubtsova N.A., Novikova E.G., Sychenkova I.Yu. Current possibilities of magnetic-resonance imaging in detection of ovarian cancer. Research’n Practical Medicine Journal. 2017; 4 (1): 40–8 (in Russ.). DOI: 10.17709/2409-2231-2017-4-1-5</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Е., Чащин А.А., Солопова А.Г., Макацария А.Д. Современные взгляды на патогенез и возможности диагностики эпителиального рака яичников. Акушерство, гинекология и репродукция. 2016; 10 (1): 75–83. DOI: 10.17749/2313-7347.2015.10.1.075-083</mixed-citation><mixed-citation xml:lang="en">Solopova A.E., Chashchin A.A., Solopova A.G., Makatsariya A.D. Current opinions concerning the pathogenesis of epithelial ovarian cancer and new diagnostic approaches to the disease. Obstetrics, Gynecology and Reproduction. 2016; 10 (1): 75–83 (in Russ.). DOI: 10.17749/2313-7347.2015.10.1.075-083</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
